Abstract | INTRODUCTION:
Bilirubin is a product of the heme catabolism pathway, and it is excreted in bile and removed from the body through the urine. Bilirubin has potent antioxidant properties but also plays a role in anti- inflammation by protecting the body against endotoxin-induced lung inflammation, down-regulating the expression of adhesion molecules, and inhibiting the infiltration of inflammatory cells. Thus, bilirubin is a promising agent that could use in inflammation disease treatment. The application of bilirubin on the "two-hit" sepsis animal model has been, to date, unknown. METHODS: RESULTS: We observed that bilirubin inhibited the expression of pro-inflammatory cytokines, while the levels of anti-inflammatory cytokines were significantly augmented in the lung. Bilirubin improved the survival rate in the sepsis model. Furthermore, we suggest that bilirubin can modulate the accumulation of T-regulatory cells and myeloid-derived suppressor cells. Notably, bilirubin suppressed the activation and functions of T-cells. CONCLUSIONS: These results clarified that bilirubin might improve tissue injury in sepsis through anti-inflammatory mechanisms.
|
Authors | Duc Tin Tran, Yong Yeon Jeong, Jeong Min Kim, Hong Bum Bae, Sung Kuk Son, Sang Hyun Kwak |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 21
Issue 22
(Nov 17 2020)
ISSN: 1422-0067 [Electronic] Switzerland |
PMID | 33212789
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Bilirubin
|
Topics |
- Animals
- Anti-Inflammatory Agents
(pharmacology)
- Bilirubin
(pharmacology)
- Disease Models, Animal
- Lymphocyte Activation
(drug effects)
- Male
- Mice
- Myeloid-Derived Suppressor Cells
(immunology, pathology)
- Sepsis
(drug therapy, immunology, pathology)
- T-Lymphocytes, Regulatory
(immunology, pathology)
|